Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses. - Wikidata - wikimedia - TriplyDB

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.

http://www.wikidata.org/entity/Q38625492

about

B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study.Immunoadsorption in patients with neuromyelitis optica spectrum disorder.Fulminant neuromyelitis optica in a Finnish woman - a case report MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.Rituximab therapy in pemphigus and other autoantibody-mediated diseases.The Role of Peripheral CNS-Directed Antibodies in Promoting Inflammatory CNS Demyelination.Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response.What's new in neuromyelitis optica? A short review for the clinical neurologist.Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.What Is the Optimal Sequence of Rescue Treatments for Attacks of Neuromyelitis Optica Spectrum Disorder?Optic Nerve.Pattern Recognition of the Multiple Sclerosis Syndrome.Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.A Rare Presentation of Neuromyelitis Optica Spectrum Disorders.Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD).Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.Tryptophan immunoadsorption during pregnancy and breastfeeding in patients with acute relapse of multiple sclerosis and neuromyelitis optica.Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis

P2860

Q26770852-B2FC7519-ADC0-4C14-9778-074963486849 Q30371412-43BA9638-BD6D-4B20-8A4B-53C97B70E23B Q36261569-424247D5-AEA3-4AA6-8CBB-3B8975FC555F Q37027700-EB0D8D0E-3B70-4524-B293-6FFA214E4448 Q37153531-98A1018F-9A4C-4F7A-9D46-490A11C1D415 Q37383555-1F7B4FF5-0C9D-4A87-B7AD-42F2C9347932 Q37620483-96D1BE86-4434-4081-80D2-9BCC068A2B79 Q38714054-CECFD982-1933-4D9C-902A-212CF66BE5DC Q38729214-19780573-7877-4C84-963A-AC9A9D2A419D Q38750021-4DD1D6CB-8FA1-4DCA-A4E7-7AC74515279A Q39176987-FE7240F8-589C-4DFA-94CC-ED56881068C9 Q39272311-E6B49002-5716-431E-9780-DDCB8660E22D Q40314562-BD59F5B9-5FFA-486F-B51D-E833E99891AA Q40481942-BC04A05F-A4EB-4968-900A-C1507D106605 Q47096340-CA15C59D-BAED-4778-9712-5E1CBDCA67ED Q47284937-4746C79A-D116-41E1-B17C-AB9C5E842202 Q47898192-A53DC624-31F6-4978-B07A-42DA0EC20721 Q48746749-21BA9EA3-0073-483A-8C78-CDE83FC1F92F Q49773507-695C1973-69C0-47B1-BE1C-BFA76E5C800A Q50067506-3A1D6AF7-486A-4473-90A5-08925ABC444A Q50194965-5EB66194-C3DE-4CEC-96F8-F7A958D18957 Q55076073-7F93D67D-24F9-49FB-BF95-E186278A1B5A Q57821319-2214A701-F23B-4009-9714-7754CCDB6F8A Q58573155-ABD2DED4-4D32-4C64-84C0-00220A41B640

P2860

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.

http://www.wikidata.org/entity/Q38625492

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.

@en

type

label

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.

@en

prefLabel

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.

@en

P1433

Q38625492-E1E5C8AD-8059-4853-BD5E-A896D75B0D62

P1476

Q38625492-00BE484A-75BC-4023-BACB-CABD9B84701C

P2093

Q38625492-0D1194EA-E86A-476C-8D87-1F3DB09DDE5A

Q38625492-11099BBD-D6ED-41BB-882D-1AE18C647FEF

Q38625492-161EC907-0C96-4985-9938-B59E86043923

Q38625492-1C32CD61-85C2-41DD-B484-AD57713E44E9

Q38625492-22784863-0FDC-4FC3-A871-718D66B532EE

Q38625492-2BCF2236-AA3F-42E4-B1A9-1E3DF9C9DAF4

Q38625492-2F6D3065-C16B-455D-8B48-051DFC4BF361

Q38625492-3FC48A22-1D92-4750-9596-9481DE345D61

Q38625492-470E36C2-6BBB-4823-8F01-8F5BB70A2D1B

Q38625492-4AA76205-5EA6-4807-B304-0ACF518AEB46

P2860

Q38625492-14583CA4-75A2-49EF-ACED-9F4B0EBFCD97

Q38625492-1530999E-DF06-4624-B951-041A4837ADCD

Q38625492-21633FE8-D2F1-4342-BF86-CDC0E0C903B7

Q38625492-2495967E-9B75-4465-BDDA-7D72C764C226

Q38625492-2B1A636A-EAC6-4A09-97A2-EE46314345A0

Q38625492-2D869B39-A2FD-4595-94A3-373A9E4F1D78

Q38625492-350698BA-E97A-49D7-A43F-724890EE4CC1

Q38625492-3BBAC36F-51B4-406A-A820-21E1FD2612DC

Q38625492-51BD6130-9177-469D-948F-FFF377BC0491

Q38625492-55E3D37B-2AB3-4D32-B390-F29BBB1169D1

P304

Q38625492-D828AD58-4B02-4FA3-A72E-758653FCEE6D

P31

Q38625492-66A9E393-5C6D-4B89-8A1C-161AFF53F1B6

Q38625492-d07d101e-e99d-4714-8d9c-83146f063d12

P356

Q38625492-581E19B5-9611-4A46-849F-77C1BA49AF9F

P433

Q38625492-57C303FE-7CC3-4651-9A7A-578339FB6F47

P478

Q38625492-56DA2DAE-DFAC-4461-A384-56DFE992BFDF

P50

Q38625492-10B6D5B4-744A-46D7-A52E-D73EE31E4FC1

Q38625492-50707B4A-53EF-47E4-A272-F817829AB4DC

Q38625492-546FB509-4FD7-4884-8E56-04B523BBCA5F

Q38625492-B921AE2D-D75C-4AA7-9C86-E12CD374AEBF

Q38625492-F0CB047F-1544-4BEA-93BD-8268E5F79936

P577

Q38625492-85461FF3-4722-44E9-B47A-60B5B9E7B24B

P5875

Q38625492-0449A8F6-43B5-44D6-9115-33701D9B495C

P698

Q38625492-01B26EE1-134C-40B8-8A1A-0A41BB11CF54

P356

P1433

Annals of Neurology

P1476

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.

@en

P2093

Achim Berthele

http://www.w3.org/2001/XMLSchema#string

Alexander Winkelmann

http://www.w3.org/2001/XMLSchema#string

Anna Gahlen

http://www.w3.org/2001/XMLSchema#string

Bernhard Hemmer

http://www.w3.org/2001/XMLSchema#string

Brigitte Wegner

http://www.w3.org/2001/XMLSchema#string

Brigitte Wildemann

http://www.w3.org/2001/XMLSchema#string

Christian Geis

http://www.w3.org/2001/XMLSchema#string

Christoph Kleinschnitz

http://www.w3.org/2001/XMLSchema#string

Christoph Mayer

http://www.w3.org/2001/XMLSchema#string

Corinna Trebst

http://www.w3.org/2001/XMLSchema#string

P2860

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

The spectrum of neuromyelitis optica.

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

[Immunoadsorption for steroid-unresponsive multiple sclerosis-relapses: clinical data of 14 patients].

Revised diagnostic criteria for neuromyelitis optica.

Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Beneficial plasma exchange response in central nervous system inflammatory demyelination.

P304

206-216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.24554

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Hans-Peter Hartung

Ulrich Hofstadt-van Oy

Klaus-Dieter Wernecke

P577

2015-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283512182

http://www.w3.org/2001/XMLSchema#string

P698

26537743

http://www.w3.org/2001/XMLSchema#string